« Previous
Next »
Medical Dosimetry
Volume 35, Issue 4
, Pages 304-311
, Winter 2010
Midline Dose Verification with Diode In Vivo Dosimetry for External Photon Therapy of Head and Neck and Pelvis Cancers During Initial Large-Field Treatments
References
- Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group No. 40. Med. Phys. 1994;21:581–618
- Quality assurance in radiotherapy: European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the ‘Europe Against Cancer Programme.’. Radiother. Oncol. 1995;35:61–73
- . Quality Assurance in Radiotherapy. Geneva, Switzerland: World Health Organization; 1988;
- AAPM code of practice for radiotherapy accelerators: Report of AAPM Radiation Therapy Task Group No. 45. Med. Phys. 1994;21:1093–1121
- . IEC 976—Medical Electrical Equipment, Medical Electron Accelerators: Functional Performance Characteristics. Geneva, Switzerland: International Electrotechnical Commission; 1989;
- American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. Med. Phys. 1998;25:1773–1829
- . Technical Reports Series No. 430: Commissioning and Quality Assurance of Computerized Planning Systems for Radiation Treatment of Cancer. Vienna: International Atomic Energy Agency; 2004;
- . AAPM Report No. 87: Diode In Vivo Dosimetry for Patients Receiving External Beam Radiation Therapy. Madison, WI: Medical Physics Publishing; 2005;
- Practical Guidelines for the Implementation of In Vivo Dosimetry with Diodes in External Radiotherapy with Photon Beams. Brussels: European Society for Therapeutic Radiology and Oncology; 2001;
- . In vivo dosimetry during external photon beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:245–259
- . Methods for In Vivo Dosimetry in External Radiotherapy. Brussels: European Society for Therapeutic Radiology and Oncology; 1994;
- Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: The appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. Radiother. Oncol. 2005;77:53–57
- The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:1113–1123
- . Limb bone bilateral asymmetry: Variability and commonality among modern humans. J. Hum. Evol. 2006;50:202–218
- Quality assurance in radiotherapy by in vivo dosimetry (2. Determination of the target absorbed dose). Radiother. Oncol. 1990;19:73–87
- . Dose perturbations due to in vivo dosimetry with diodes. Radiother. Oncol. 1997;42:289–291
- In vivo dosimetry for external photon treatments of head and neck cancers by diodes and TLDs. Radiat. Prot. Dos. 2004;111:45–50
- Detection of errors in individual patients in radiotherapy by systematic in vivo dosimetry. Radiother. Oncol. 1995;34:144–151
- . Supplementary details on codes of practice for absolute dose determination. In: Mayles P, Nahum AE, Rosenwald JC editor. Handbook of Radiotherapy Physics: Theory and Practice. London: Taylor & Francis; 2007;p. 401
- . Formulae for the determination of percentage depth dose of 8 and 16 megavolt x-rays by means of a computer. S. Afr. Med. J. 1982;62:437–440
PII: S0958-3947(10)00034-8
doi: 10.1016/j.meddos.2010.03.007
© 2010 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Medical Dosimetry
Volume 35, Issue 4
, Pages 304-311
, Winter 2010
